Ferhan Qureshi
About Ferhan Qureshi
Ferhan Qureshi is the Senior Vice President of Biomarker R&D, known for his work on serum protein biomarkers for Optic Neuritis in multiple sclerosis patients.
Title: Senior Vice President, Biomarker R&D
Ferhan Qureshi holds the position of Senior Vice President in Biomarker Research & Development (R&D). As a key leader in the department, Qureshi focuses on the development and validation of biomarkers that have significant clinical applications. This role involves overseeing R&D projects, managing interdisciplinary teams, and contributing to the strategic direction of the company's biomarker initiatives.
Presentation at 2024 AAN Annual Meeting
Ferhan Qureshi presented findings on Optic Neuritis at the 2024 Annual Meeting of the American Academy of Neurology (AAN). This presentation covered critical insights regarding the predictive utility of serum protein biomarkers, offering new perspectives in understanding and managing Optic Neuritis events, particularly in individuals diagnosed with multiple sclerosis.
Research Focus: Serum Protein Biomarkers for Optic Neuritis
Ferhan Qureshi’s research is focused on the predictive utility of serum protein biomarkers for Optic Neuritis events in individuals with multiple sclerosis. This research aims to improve diagnostic accuracy and therapeutic interventions by identifying key biomarkers in serum proteins that may predict the occurrence of Optic Neuritis, thereby aiding in better disease management and patient care.